申请人:NERVIANO MEDICAL SCIENCES S.R.L.
公开号:US20190241546A1
公开(公告)日:2019-08-08
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.